Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT01249430 · COMPLETED
Trial details
- NCT number
- NCT01249430
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-20
- Primary completion
- 2013-05-24
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.